Respiratory Medications and Devices Update 2/15

Size: px
Start display at page:

Download "Respiratory Medications and Devices Update 2/15"

Transcription

1 Respiratory Medications and Devices Update 2/15 Dewey Hahlbohm, PA-C, AE-C Wendy Brown, Pharm.D., MPAS, PA-C, AE-C Objectives! Review mechanism of action for asthma pharmacologic agents! Describe key patient educational points for each! Compare and contrast various aerosol delivery devices including proper technique and limitations of device! Outline care and cleaning of devices

2 Pharmacotherapy! Antiinflammatory (controller/maintenance) versus bronchodilators (rescue/reliever) meds! Educate pts,! Role of medications! Role of monitoring! Role of treatment plans Long-term control medications! EPR-3 recommends long-term control medications be taken on a daily basis for treatment of persistent asthma! Inhaled corticosteroids (ICS)! Inhaled long-acting bronchodilators (LABA)! Leukotriene modifiers (Singulair)! Theophylline! Immunomodulators

3 Inhaled corticosteroids (ICS)! Most potent and consistently effective long-term control medication for treatment of asthma! Work on Airway inflammation through a variety of mechanisms! Effects: Decrease severity of symptoms, improve control and QOL, improve peak flow and spirometry, prevent exacerbations and decrease systemic corticosteroid use, ED visits, hospitalization and death Benefits of ICS! Increase number of!2- adrenergic receptors and improve the receptor responsiveness to!2- adrenergic stimulation?! Reduce mucous production and hypersecretion! Reduce bronchial hyperresponsiveness! Reduce airway edema and exudation

4 ICS: Local Adverse Effects! Oral candidiasis (thrush)! 45-58% of patients have + cultures (clinical thrush 0-34%)! Not as common with lower doses (5%)! Dysphonia! 5-50% of patients! Reflex cough and bronchospasm ICS: Systemic Adverse Effects! Linear growth:! Low-med dose ICS may have potential to decrease growth velocity in children! Effects are small and may be reversible! Studies show improved asthma outcomes in children! Expert Panel statements:! Risk is well balanced by benefits! Effects may be dose dependent! Poorly controlled asthma may delay growth in children! Effect typically occurs in first several months! Growth should be monitored

5 Generic Brand Dose/actuation notes Fluticasone Flovent 44, 110, 220 mcg 100, 250, 500 mcg HFA MDI Discus Triamcinolone acetonide Azmacort 100 mcg MDI with built in spacer Beclomethasone dipropionate QVAR 40 mcg 80 mcg HFA MDI Flunisolide Aerobid 250 mcg HFA MDI Budesonide Nebulizer suspension Pulmicort 200 mcg 0.25, 05 mg DPI, Turbuhaler Only available product for neb Mometasone furoate Azmanex twisthaler 110 mcg 220 mcg Breath-activated Once daily dosing Ciclesonide Alvesco 80 mcg, 160mcg, MDI, once daily dosing Dosing of ICS Ciclesonide Inhaled 80, 160 mcg/puff NA NA 320mcg NA NA > mcg NA NA >640mcg Adapted from: _asthma_guidelines.pdf

6 Combo Products Product Dosage Form Dose Fluticasone/ Salmeterol (Advair ) DPI: 100/50; 250/50; 500/50 HFA: 45/21; 115/21; 230/21 1 blister q 12 hours 2 inhalations q 12 hours Discus approved for kids >4 HFA approved for kids > 12 Budesonide/ Formoterol (Symbicort ) HFA: 80/4.5; 160/4.5 Two inhalations twice daily Approved for kids >12 Mometasone/ Formoterol (Dulera ) HFA: 100/5; 200/5 Two inhalations twice daily Approved for kids >12

7 Inhaled Corticosteroids Teach patient: About delay of onset Importance of taking every day Proper technique Use spacer for MDI RINSE and SPIT after each use Decrease oral thrush, dysphonia When to change canister Fear of steroids is common/need to provide accurate counseling/education to pts Leukotriene Modifiers Work on arachadonic acid cascade! Block leukotriene D4 (potent vasoconstrictor)! D4 at least 1000 times more potent than histamine! Leukotrients are inflammatory mediators that mediate airway obstruction, hyperresponsiveness and inflammation

8 Leukotriene Modifiers Dosage Form Adult dose Child Dose Comment Montelukast Singulair 4,5 mg chewtabs 10 mg tab 10 mg qhs Age: 2-5 y.o 4 mg qhs Age: 6-14 y.o. 5 mg qhs Age: >14 y.o. 10 mg qhs Has captured nearly all of the market for leukotriene modifiers Zafirlukast Accolate Zileuton Zyflo 10, 20 mg tab 20 mg bid Age: mg bid 300, 600 mg tab 2400 mg qday qid Has not been studied in kids <12 y.o Take 1 hr before/2hr after meals Monitor LFTs Monitor LFTs Long-Acting Bronchodialators (Beta 2 agonists)! EPR-3: Preferred adjunctive treatment to ICS for longterm control for step 3 in adults and children >12; steps 4 and 5 for kids 5-11 y.o. for long-term control of symptoms! Not recommended as monotherapy! No anti-inflammatory properties! Not recommended to treat acute symptoms

9 Long-Acting Bronchodilators (Beta 2 agonists)! MOA: relax bronchial smooth muscle by stimulating B2 receptors! B2 receptors found throughout respiratory tract! Duration of action: 12 hours not to be used more than twice daily LABA Indications: adjunctive therapy for moderate-severe persistent asthma Should NOT be used for EIB Products: Formoterol (Foradil ) 5 minute onset Salmeterol (Serevent ) 30 minute onset ADRs: headache, palpitations, tremor, nausea and vomiting

10 Long-Acting Beta-2 agonists: Therapeutic Issues: SMART Trial (Serevent Multi-center Asthma Research Trial) servent.htm! Compared to placebo: Serevent MAY be associated with increased risk of respiratory-related deaths/resp.- related life-threatening experiences! More prominent in African-Americans! Steroids under-utilized in SMART trial! LABAs should never be used as monotherapy

11 Combo products Product Dosage Form Dose Fluticasone/ Salmeterol (Advair ) DPI: 100/50; 250/50; 500/50 HFA: 45/21; 115/21; 230/21 1 blister q 12 hours 2 inhalations q 12 hours Discus approved for kids >4 HFA approved for kids > 12 Budesonide/ Formoterol (Symbicort ) HFA: 80/4.5; 160/4.5 Two inhalations twice daily Approved for kids >12 Mometasone/ Formoterol (Dulera ) HFA: 100/5; 200/5 Two inhalations twice daily Approved for kids >12

12 Combination Therapy

13 Omalizumab (Xolair )! EPR-3: recommended for step 5 and 6 care in patients who have allergies and who are inadequately controlled by high-dose ICS and LABA! Recombinant Anti-IgE monoclonal antibody! MOA: binds free IgE and IgE mast cells which leads to decrease in the release of mediators in response to allergen exposure! Approved in ages >12 y.o. with allergic asthma! Subcutaneous injection q 2-4 wks depending on baseline IgE levels and pts wt! Anaphylaxis has occurred: administered under medical supervision Anticholinergics! Limited role in asthma/first line in COPD! MOA: Inhibits muscarinic cholinergic receptors! Bronchodilation, reduces intrinsic vagal tone, may reduce mucous gland secretions! Adverse Effects: Dry mouth! Do not block EIB

14 Anticholinergics Long Acting Muscurinic Antagonists (LAMAS)! Tiotropium (Spiriva )! Convenient qday dosing via handihaler! Respimat formulation just released in 2015! Peak effect in 3 hours, durations 24 hours! Aclidinium (Tudorza)! Breath-actuated DPI: BID dosing! Duration 12 hours Tiotropium (Spiriva )! Long acting inhaled anticholinergic indicated for COPD. No role in asthma treatment

15 (Aclidinium bromide)tudorza! Long acting anticholinergic: Not indicated for asthma Anticholinergic Short acting Muscurinic Antagonists (SAMA)! Ipratropium bromide (Atrovent ):! Used with short-acting B2 agonist in multiple doses in moderate to severe asthma exacerbations in the emergency department! Combination product (albuterol/ipratropium-atrovent ) off of the market! Combivent respimat new product to replace atrovent! Peak affect hours, duration 4-6 hours

16 Combivent Respimat Quick-relief medicine! Prompt reversal of bronchoconstiction and accompanying symptoms (cough, chest tightness, wheeze, etc)! Short-acting B2-agonists! Anticholinergics! Systemic corticosteroids! Used for exacerbations

17 Short-acting B2-agonists! Smooth muscle relaxation! Rapid-onset of action: min! Duration of action: 4-6 hours! Use q 4 hours PRN (routine dosing discouraged)! May use min before exercise to prevent symptoms! Should always be available to patient Beta-2 Agonists Potential Adverse effects of both LABA and SABA Frequency and severity of ADRs directly related to dose and dosing frequency For typical short-acting, inhaled beta-2 agonists Frequency 1-5% Typical ADR s Headache/dizziness/vertigo Palpitations Tremor Nausea/vomiting ADRs with overuse: Hypokalemia Prolonged QTC interval

18 Short-acting B2-Agonists: Warning Signals! Needing more than every 4 hours! Needing every 4 hours all day long! Not responding to treatment within 15 min! Control: needing quick-relief less than twice weekly Short Acting B2 Agonist Albuterol HFA MDI (Pro-Air, Proventil, Ventolin) Also available as solution for nebulizer Levalbuterol MDI (Xopenex) Also available as solution for nebulizer

19 Inhaled Medication! Advantages! Rapid Onset of Action! Low incidence of systemic side effects! Success of inhaled medication dependent on:! Medication deposition! Particle size (2-5 microns desirable)! Inhalation mode! Patient features

20 Optimum inspiratory flow! Delivery to lungs is dependent on inspiratory airflow and medication device resistance! Inspiratory flow requirements may vary between devices Optimum inspiratory flow! Device Optimum Inspiratory Flow! Diskus L/min! Flexhaler L/min! Autohaler L/min! MDI L/min! Aerolizer L/min! Twisthaler L/min! Handihaler L/min

21 Metered Dose Inhaler! Teach closed mouth technique! 10-30% of the dose from the MDI delivered to lungs, 80% is swallowed! Problems:! Techniques! Hand lung coordination! Too brief breath hold! Inspiratrory flow too rapid! Insufficient canister shaking! Spraying in mouth breathing through the nose Metered Dose Inhaler! Technique:! Shake 6-10 times! Tilt head back slightly and breathe out slowly to empty lungs! Position the inhaler in mouth, between teeth with lips around the mouthpiece! Press down and slowly breath in for 3-5 seconds! Hold breath 10 seconds! Wait 1 minute before another puff

22 Factors affecting Dose Uniformity With Metered Dose Inhalers! Factors affecting Dose uniformity with MDI! Loss of Prime! Problem: After period of no use, first dose may be reduced or absent! Cause: Propellant drained from metering chamber! Loss of Dose! Problem: Dose diminishes, but is unnoticed because propellent remains the same! Cause: Active ingredient creams or settles! Tailing off! Problem: Erratic drug delivery after labeled number of doses! Cause: Metering chamber fills with vapor rather than propellent Education for dose uniformity! When to prime! Clean device! Remove canister: rinse in warm water! Clean at least once/week and as often as daily White stuff around the mouth piece can slow delivery! Teach patient to know when inhaler is gone: either tick method(count number of puffs used(easier to do with maintenance meds), or check dose counter

23 Spacers! Enhance aerosol delivery! Decrease need for coordination! Decrease systemic side effects! Reduce deposition in the oral cavity! Required for corticosteroids (decrease incidence of local side effects) Dry Powder inhalers for asthma! Diskus (Serevent, Flovent, Advair) multidose discrete dose! Flexhaler (Pulmicort) -- multidose reservoir! Twisthaler (Asmanex) multidose reservoir! Aerolizer (Foradil) single dose discrete dose

24 Dry Powder Inhalers! Fast deep breath as opposed to slow deep breath with MDI! General Care:! Keep dry at room temp! Never put in water! Wipe mouthpiece with tissue to clean! Never shake after dose is loaded! Never breath in to device Dry Powder Inhaler! Advantages:! No propellants! Improved Airway deposition! Eliminated need for spacer! Easy to teach and learn! Dose counters are included! Disadvantages:! Ability to be affected by humid air! No quick relief devices! Different devices require different flowrates technique isn t standardized

25 Diskus (Advair, Flovent)! Diskus DPI:! Mulitdose (60 doses)! Delivers about 90% of labeled dose at wide range of flow rates! Desirable for pts who have fluctuating flow rates with variation of ds.! Counter! Advantage: if you forget to put lever back you meet resistance! Use: click, click, breath in strong, steady and as deeply as possible, close to reset

26 Pulmicort Flexhaler! Multidose: 180 mcg 120 doses; 90 mcg 60 doses! More resistance to inhalation and requires more forceful inspiratory flow rates for consistent dosing! Variability of doses at different flow rates is higher than other devices! Dose indicator below mouthpiece red 20 doses! Priming: done with a new device! Remove Cover! Twist brown grip on bottom fully to the right then back to the left! You will hear a click, Repeat Pulmicort flexhaler! Using:! Remove cover! Hold upright! Twist brown grip fully to left then right click! Place in mouth! Breath in as quickly and deeply as possible! Hold 10 seconds! Replace cover twist to close

27 Asmanex Twisthaler! Multi-dose DPI. Contains 30,60, or 120 doses.! Use:! Open: hold the inhaler upright with the base on the bottom! Grip the base and twist the cap counterclockwise while keeping the inhaler in an upright position! As the cap is lifted off the dose counter counts down by one! Inhale dose: exhale fully, firmly close lips around the mouthpiece and take a fast, deep breath while holding the mouthpiece in a horizontal position,! Remove the inhaler from your mouth and hold breath for 10 seconds! Replace the cap and twist it clockwise until it clicks(the cap must be fully closed to load the next dose! Check to make sure that the arrow is lined up with the dose counter Asmanex Twisthaler

28 Foradil Aerolizer! Use! Dose placed into device before using! Capsule in foil! Pierce capsule! Never breath into mouthpiece! Whirring noise when inhaling should be heard! Sweet taste! Always discard empty capsule! Breath in rapidly steadily and completely Nebulizers! Advantages! Coordination of inspiration and treatment not required! use in infants, children, elderly, patient preference: allows slower, relaxed breathing during asthma flare, use for acute exacerbations! Disadvantages:! Cost and care issues! Length of treatment! Portability

29 Nebulizers! In general we should encourage patients to use MDI/DPI: can get same amount of medication with proper technique and much more convenient! Blow by technique used when mask intolerable. Directs aerosol towards nose and mouth with reservoir tube. NO DATA behind this.! Better to administer with close fit mask when child is asleep Nebulizers! Crying: completely prevents lower airway deposition in distressed child! "Kids <5 should use close fitting mask for nebs! Pulmicort respules should always be given with sealed mask to prevent getting in eyes, wipe mouth after use! Mouthpiece can start to be used around the age of 5! Pulmicort is the only ICS for nebulizer! "Dead volume: give neb until it sputters then tap and when it sputters no more will come out. The amount left is referred to as the dead volume This may be up to 1 ml depending on the neb

30 Nebulizers! Disposable Nebulizer! Changed every 2 weeks with regular daily use! Wash daily with mild detergent! Rinse well in running water and air dry completely! Disinfect regularly 1:3 dilution of white vinegar and water! Every 3 rd day! Soak 20 min rinse well air dry! Reusable Nebulizer:! Cleaned and reused for up to 6 months! Some dishwasher safe! Store in plastic ziplock bag once dry! Neb cup rinsed after each treatment to eliminate leftover meds Only in Montana

31 Questions? Thanks for being here, enjoy the rest of your Asthma Educator Conference

10/18/2012. Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C

10/18/2012. Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C Daily: Long-Term Control Corticosteroids (inhaled and systemic) Long-acting beta 2 -agonists (Serevent, Foradil) Methylxanthines

More information

The Medical Letter. on Drugs and Therapeutics

The Medical Letter. on Drugs and Therapeutics The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call:

More information

Question I was one of the first dry power devices available in the US Flovent, Serevent and Advair are all available in this device

Question I was one of the first dry power devices available in the US Flovent, Serevent and Advair are all available in this device What Device am I Class Side Effects History Potpourri Monitoring Tools 10 10 10 10 10 20 20 20 20 20 30 30 30 30 30 40 40 40 40 40 50 50 50 50 50 WHAT KIND OF DEVICE AM I? I was one of the first dry power

More information

COPD Medicine. No one ever showed me how to use this. Wendy Happel; RRT, COPD Educator Krystal Fedoris; RRT-NPS, BA, COPD Educator

COPD Medicine. No one ever showed me how to use this. Wendy Happel; RRT, COPD Educator Krystal Fedoris; RRT-NPS, BA, COPD Educator Medicine. No one ever showed me how to use this. Wendy Happel; RRT, Educator Krystal Fedoris; RRT-NPS, BA, Educator 1 Taking prescriptions correctly Taking prescriptions can be a challenge Busy schedules

More information

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) BREEZHALER Please date initial after you have directly observed

More information

How to Use Inhaled Medications for Asthma and COPD

How to Use Inhaled Medications for Asthma and COPD How to Use Inhaled Medications for Asthma and COPD This information is not intended to diagnose health problems or to take the place of medical advice or care you receive from your physician or other health

More information

Diagnosis and Management of Asthma

Diagnosis and Management of Asthma Supporting Evidence: Diagnosis and Management of Asthma The subdivision of this section is: Appendix B Tables Copyright 2016 by 1 Eleventh Edition/December 2016 Appendix B Asthma Summary Tables Class:

More information

Foundations of Pharmacology

Foundations of Pharmacology Pharmacologic Management of Asthma Objectives: 1. Review the physiological basis for asthma therapy 2. Discuss the differences between SABA and LABA 3. Discuss the role of inhaled and oral systemic corticosteroids

More information

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) BREEZHALER Please date initial after you have directly observed

More information

Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath.

Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath. Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath. AccuNeb inhalation 0.021% solution: 0.63mg/3mL 3-4 times solution

More information

Ferris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS

Ferris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS Ferris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS Objectives Categorize the new asthma and COPD inhalers in to existing or newly created categories Discuss the

More information

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) BREEZHALER Please date initial after you have directly observed

More information

A Visual Approach to Simplifying Respiratory Drug Regimens

A Visual Approach to Simplifying Respiratory Drug Regimens A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP 3 Main Categories Inhaled Respiratory Drugs Binds to beta-2 receptors Relaxation of smooth muscles in the lung

More information

12/18/2017. Disclosures. Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing

12/18/2017. Disclosures. Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing Diana M. Sobieraj, PharmD, BCPS Assistant Professor University of Connecticut School

More information

Correct Use of Inhaler Devices

Correct Use of Inhaler Devices PL Detail-Document #300206 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER February 2014 Correct Use of

More information

How to Use Inhaled Medications

How to Use Inhaled Medications How to Use Inhaled Medications FOR ASTHMA AND COPD introduction Inhaled medications are an important part of controlling and treating asthma and chronic obstructive pulmonary disease (COPD). The medication

More information

Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing

Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing Diana M. Sobieraj, PharmD, BCPS Assistant Professor University of Connecticut School

More information

Your Inhaler Devices & You

Your Inhaler Devices & You 1 Your Inhaler Devices & You COUNSEL ON THE APPROPRIATE USE OF A: METERED DOSE INHALER (MDI) DRY POWDER INHALER (DPI) DISCUSS THE APPROPRIATE USAGE OF A PEAK FLOW METER AND SPACER/HOLDING CHAMBER DEVICE

More information

Aerosol Delivery Devices

Aerosol Delivery Devices Aerosol Delivery Devices Judy Bielenda LRRT Respiratory Therapy Clinical Specialist Pediatric Asthma Education Coordinator University of Michigan C.S. Mott Children s and Von Voigtlander Women s Hospital

More information

MANAGING ASTHMA. Nancy Davis, RRT, AE-C

MANAGING ASTHMA. Nancy Davis, RRT, AE-C MANAGING ASTHMA Nancy Davis, RRT, AE-C What is asthma? Asthma is a chronic respiratory disease characterized by episodes or attacks of inflammation and narrowing of small airways in response to asthma

More information

A Visual Approach to Simplifying Respiratory Drug Regimens

A Visual Approach to Simplifying Respiratory Drug Regimens Adverse Effects of Inhaled Medications A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP June 28, 2017 Drug Category Beta 2 agonists antagonists Adverse Effects

More information

A Visual Approach to Simplifying Respiratory Drug Regimens

A Visual Approach to Simplifying Respiratory Drug Regimens A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP October 23, 2017 Learning Objectives Be able to list at least 3 major adverse effects of inhaled medications

More information

What You Need to Know about Metered-Dose Inhalers and the HFA Propellant

What You Need to Know about Metered-Dose Inhalers and the HFA Propellant What You Need to Know about Metered- Inhalers and the HFA Propellant There are a number ways to deliver inhaled medication. They include: Metered-dose inhaler () Metered-dose inhaler with spacer/holding

More information

How can I benefit most from my COPD medications?

How can I benefit most from my COPD medications? Fact Sheet: COPD Medications and Delivery Devices How can I benefit most from my COPD medications? COPD medications can improve your symptoms. By taking the right medication at the right time, you can

More information

Pocket Guide to Inhaler Technique A Step-By-Step Guide for Healthcare Professionals

Pocket Guide to Inhaler Technique A Step-By-Step Guide for Healthcare Professionals Pocket Guide to Inhaler Technique A Step-By-Step Guide for Healthcare Professionals Endorsed by NHSGGC Respiratory Managed Clinical Network; June 2016 Designed by Medical Illustration Services Contents

More information

MDI Bonanza. Dwayne Griffin, DO

MDI Bonanza. Dwayne Griffin, DO MDI Bonanza Dwayne Griffin, DO Bonanza 3. A MDI costing $200 - $500 per month SISYPHUS MDI Griffin Mountain Evolution of Deliver Systems for COPD in the US 2003 2009 2011 2013 2004 2012 2014 Prescribing

More information

Asthma medications: Know your options - MayoClinic.com. Asthma medications: Know your options

Asthma medications: Know your options - MayoClinic.com. Asthma medications: Know your options MayoClinic.com reprints This single copy is for your personal, noncommercial use only. For permission to reprint multiple copies or to order presentation-ready copies for distribution, use the reprints

More information

Medications for Managing COPD in Hospice Patients. Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources

Medications for Managing COPD in Hospice Patients. Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources Medications for Managing COPD in Hospice Patients Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources Goal of medications in COPD Decrease symptoms and/or complications Reduce frequency

More information

Appendix M: Device Technique

Appendix M: Device Technique Nursing Care of Dyspnea: The 6th Vital Sign in Individuals with Chronic Obstructive Pulmonary Disease (COPD) Appendix M: Device Technique Medications: Inhalation Devices Medications come in many forms.

More information

Drugs that Affect the Respiratory System BROOKE BENTLEY, PHD, APRN

Drugs that Affect the Respiratory System BROOKE BENTLEY, PHD, APRN Drugs that Affect the Respiratory System BROOKE BENTLEY, PHD, APRN Goals of Therapy Asthma Prevent symptoms COPD Reduce COPD symptoms Decrease use of SABAs Maintain normal pulm function & prevent loss

More information

Breezhaler. Open to see clear capsule. How do I use my Breezhaler? Care of my Breezhaler

Breezhaler. Open to see clear capsule. How do I use my Breezhaler? Care of my Breezhaler Breezhaler 3 Pull cap off Press buttons once and release Breathe in rapidly and steadily. Hold. Open. Place capsule in chamber. Close (click). Breathe out 4 Open to see clear capsule. If not all clear

More information

Medications Affecting The Respiratory System

Medications Affecting The Respiratory System Medications Affecting The Respiratory System Overview Asthma is a chronic inflammatory disorder of the airways. It is an intermittent and reversible airflow obstruction that affects the bronchioles. The

More information

TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder

TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific

More information

Reference Guide for Caring for Pediatric Patients with Asthma

Reference Guide for Caring for Pediatric Patients with Asthma Reference Guide for Caring for Pediatric Patients with Asthma Co-Chair: Nancy Cantey Banasiak, DNP, PPCNP-BC, APRN Co-Chair: Deborah Hickman, DNP, APRN-CNP, CPNP-PC, NNP-BC Asthma and Allergy SIG Members

More information

Key features and changes to these four components of asthma care include:

Key features and changes to these four components of asthma care include: Guidelines for the Diagnosis and Management of Asthma in Adults Clinical Practice Guideline MedStar Health These guidelines are provided to assist physicians and other clinicians in making decisions regarding

More information

Common Inhaled Asthma Medications Dose Comparison and Tips for Use

Common Inhaled Asthma Medications Dose Comparison and Tips for Use Detail-Document #210303 This Detail-Document accompanies the related article published in PHARMACIST S LETTER / PRESCRIBER S LETTER March 2005 ~ Volume 21 ~ Number 210303 Common Inhaled Asthma Medications

More information

Asthma. Definition. Symptoms

Asthma. Definition. Symptoms Asthma Definition Asthma is a condition in which your airways narrow and swell and produce extra mucus. This can make breathing difficult and trigger coughing, wheezing and shortness of breath. For some

More information

Nancy Davis, RRT, AE-C

Nancy Davis, RRT, AE-C Nancy Davis, RRT, AE-C Asthma Statistics 25.6 million Americans diagnosed with asthma 6.8 million are children 10.5 million missed school days per year 14.2 lost work days for adults Approximately 10%

More information

Appendix E: Device Technique

Appendix E: Device Technique Adult Asthma Care Guidelines for Nurses: Promoting Control of Asthma Appendix E: Device Technique Medications: Inhalation Devices Adapted with permission from The Lung Association: www.lung.ca/asthma/manage/devices.html

More information

NEBULIZERS, METERED DOSE INHALERS, AND DRY POWDER INHALERS

NEBULIZERS, METERED DOSE INHALERS, AND DRY POWDER INHALERS NEBULIZERS, METERED DOSE INHALERS, AND DRY POWDER INHALERS Douglas S. Gardenhire, Ed.D, RRT-NPS MODULE 1 Manipulate Small Volume Nebulizers by Order or Protocol 1 Objectives for Module 1 At the end of

More information

Respiratory Health. Asthma and COPD

Respiratory Health. Asthma and COPD Respiratory Health Asthma and COPD Definition of asthma Working definition by AAH 2014: Chronic lung disease Can be controlled not cured Large variation in lung function Large variation in respiratory

More information

Using Inhaled Corticosteroids as Needed for Asthma: giving patients relief or leaving them breathless?

Using Inhaled Corticosteroids as Needed for Asthma: giving patients relief or leaving them breathless? Using Inhaled Corticosteroids as Needed for Asthma: giving patients relief or leaving them breathless? Lindsay Thomas, Pharm.D. PGY2 Ambulatory Care Resident Department of Pharmacotherapy and Pharmacy

More information

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 07/05/18 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 07/05/18 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE: CINQAIR (reslizumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs

More information

COPD RESOURCE PACK Section 5. Drug Treatment & Inhalers in Stable COPD

COPD RESOURCE PACK Section 5. Drug Treatment & Inhalers in Stable COPD COPD RESOURCE PACK Section 5 Drug Treatment & Inhalers in Stable COPD In this section: 1. Links to Fife Formulary 2. Pharmacological Management of Stable COPD 3. How to use a Metered Dose Inhaler 4. How

More information

INHALERS for COPD INTRODUCTION. Types of inhalers. Inhaler technique. MDIs for COPD WET AEROSOLS. Dr Christopher Worsnop

INHALERS for COPD INTRODUCTION. Types of inhalers. Inhaler technique. MDIs for COPD WET AEROSOLS. Dr Christopher Worsnop INHALERS for COPD Dr Christopher Worsnop Department of Respiratory Medicine Austin Hospital INTRODUCTION Most drugs for COPD are given via inhalers. This reduces the dose that needs to be given and delivers

More information

Using an Inhaler and Nebulizer

Using an Inhaler and Nebulizer Using an Inhaler and Nebulizer Introduction An inhaler is a handheld device that is used to deliver medication directly to your airways. A nebulizer is an electric or battery powered machine that turns

More information

primer on inhalers and nebulizers

primer on inhalers and nebulizers CREDIT: 2.0 Continuing Education EARN CE CREDIT FOR THIS ACTIVITY AT WWW.DRUGTOPICS.COM AN ONGOING CE PROGRAM OF THE UNIVERSITY OF CONNECTICUT SCHOOL OF PHARMACY AND DRUG TOPICS educational objectives

More information

Guide to Inhaled Treatment Choices

Guide to Inhaled Treatment Choices Guide to Inhaled Treatment Choices Note: this is guidance only, it is important to consider which device is best suited to the patient. This may NOT be the first line choice (but should be on the joint

More information

Guide to Inhaled Treatment Choices

Guide to Inhaled Treatment Choices Guide to Inhaled Treatment Choices Note: this is guidance only, it is important to consider which device is best suited to the patient. This may NOT be the first line choice (but should be on the joint

More information

End Stage COPD Guidance Document

End Stage COPD Guidance Document End Stage COPD Guidance Document Suggested Guidelines for the Determination of Hospice Eligibility A patient with severe chronic pulmonary disease that meets the following criteria may be eligible for

More information

2008 IPAC-RS Conference Doing the Right Thing Science, Quality and Patient Focus

2008 IPAC-RS Conference Doing the Right Thing Science, Quality and Patient Focus 2008 IPAC-RS Conference Doing the Right Thing Science, Quality and Patient Focus Patient Perspective Alpha-1 1 Foundation John W. Walsh Patient Focus Personal perspective Challenges and lessons Importance

More information

Allergies and Asthma 5/21/2013. Objectives. Allergic Rhinitis (AR): Risk Factor for ASTHMA. Rhinitis and Asthma

Allergies and Asthma 5/21/2013. Objectives. Allergic Rhinitis (AR): Risk Factor for ASTHMA. Rhinitis and Asthma Allergies and Asthma Presented By: Dr. Fadwa Gillanders, Pharm.D Clinical Pharmacy Specialist May 2013 Objectives Understand the relationship between asthma and allergic rhinitis Understand what is going

More information

FASENRA (benralizumab)

FASENRA (benralizumab) FASENRA (benralizumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs

More information

Metered Dose Inhaler (MDI)

Metered Dose Inhaler (MDI) Metered Dose Inhaler (MDI) If the inhaler has not been used before, a test dose should be fired into the air to prime the system. 1. Remove cap. 2. Shake well. 3. Breathe out fully. 4. Holding inhaler

More information

Disclosure. Case. Objectives. Case Continued. Inhalers. Asthma: A GINA Update to the NAEPP 2007 Guidelines 1/20/2015

Disclosure. Case. Objectives. Case Continued. Inhalers. Asthma: A GINA Update to the NAEPP 2007 Guidelines 1/20/2015 Disclosure Asthma: A GINA Update to the NAEPP 2007 Guidelines Robert (RC) Hellinga, Pharm.D. PGY 1 Pharmacy Resident Wolfson Children s Hospital/Baptist Health I do not have a vested interest in or affiliation

More information

GMMMG Asthma Formulary Inhaler Options August 2017

GMMMG Asthma Formulary Inhaler Options August 2017 Regular Preventer Beclometasone Beclometasone Beclometasone Brand name Qvar Easi-Breathe Clenil Modulite Easyhaler Device MDI MDI DPI Strengths 50 microgram 100 microgram 200 microgram Adult asthma 2 inhalations

More information

Asthma in Pregnancy. Asthma. Chronic Airway Inflammation. Objective Measures of Airflow. Peak exp. flow rate (PEFR)

Asthma in Pregnancy. Asthma. Chronic Airway Inflammation. Objective Measures of Airflow. Peak exp. flow rate (PEFR) Chronic Airway Inflammation Asthma in Pregnancy Robin Field, MD Maternal Fetal Medicine Kaiser Permanente San Francisco Asthma Chronic airway inflammation increased airway responsiveness to a variety of

More information

Drug Class Monograph

Drug Class Monograph Drug Class Monograph Class: Inhaled Corticosteroids Drugs: Aerospan (flunisolide), Advair Diskus, Advair HFA (fluticasone/salmeterol), Alvesco (ciclesonide), Arnuity Ellipta (fluticasone furoate), Asmanex

More information

Asthma training. Mike Levin Division of Asthma and Allergy Red Cross Hospital

Asthma training. Mike Levin Division of Asthma and Allergy Red Cross Hospital Asthma training Mike Levin Division of Asthma and Allergy Red Cross Hospital Introduction Physiology Diagnosis Severity Treatment Control Stage 3 of guidelines Acute asthma Drug delivery Conclusion Overview

More information

Asthma By Mayo Clinic staff

Asthma By Mayo Clinic staff MayoClinic.com reprints This single copy is for your personal, noncommercial use only. For permission to reprint multiple copies or to order presentation-ready copies for distribution, use the reprints

More information

MEDICATION GUIDE. ADVAIR [ad vair] HFA 45/21 (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol

MEDICATION GUIDE. ADVAIR [ad vair] HFA 45/21 (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol MEDICATION GUIDE ADVAIR [ad vair] HFA 45/21 (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol ADVAIR HFA 115/21 (fluticasone propionate 115 mcg and salmeterol 21 mcg) Inhalation

More information

ASTHMA BEST PRACTICES FOR SCHOOL NURSES. School Nurses November 2015

ASTHMA BEST PRACTICES FOR SCHOOL NURSES. School Nurses November 2015 ASTHMA BEST PRACTICES FOR SCHOOL NURSES School Nurses November 2015 1 BACKGROUND AND CURRENT STATS General definitions and explanations 2 Incidence of Asthma Centers for Disease Control (CDC) - 1 in 12

More information

AIRDUO RESPICLICK (fluticasone-salmeterol) aerosol DULERA (mometasone furoate and formoterol fumarate dihydrate) aerosol

AIRDUO RESPICLICK (fluticasone-salmeterol) aerosol DULERA (mometasone furoate and formoterol fumarate dihydrate) aerosol DULERA (mometasone furoate and formoterol fumarate dihydrate) aerosol Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific

More information

Inhalation devices, proper technique and cleaning

Inhalation devices, proper technique and cleaning Preventing Your Symptoms and Taking Your Medications Inhalation devices, proper technique and cleaning Knowing how to use your medications properly is important because inhaled drugs are meant to get directly

More information

COPD Update: Focus on Intensifying LABA, LAMA and ICS Therapy

COPD Update: Focus on Intensifying LABA, LAMA and ICS Therapy Update: Focus on Intensifying LABA, LAMA and ICS Therapy B.C. Provincial Academic Detailing Service February 2017 Background In Canada, approximately 20 inhaled medications are approved to treat Chronic

More information

Staying Healthy. with Asthma. Illustrations by paulsharp.com

Staying Healthy. with Asthma. Illustrations by paulsharp.com Staying Healthy with Asthma Illustrations by paulsharp.com Lungs & Asthma What is Asthma? Inflammation or swelling of airways that leads to: 1) Mucous production deep inside the airways. 2) Temporary difficulty

More information

Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma

Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma Magnitude of Asthma - India Delhi Childhood asthma: 10.9% Adults: 8% Other Cities 3 to 18% Chhabra SK et al Ann Allergy Asthma

More information

CARE AT HOME: ASTHMA. A guide for parents. childrensmn.org

CARE AT HOME: ASTHMA. A guide for parents. childrensmn.org CARE AT HOME: ASTHMA A guide for parents childrensmn.org Content Your child has asthma a chronic lung disease. To best control the symptoms of asthma, it is important that you learn all you can about asthma.

More information

Pharmacist Objectives. Pulmonary Update. Outline. Technician Objectives. GOLD Guidelines. COPD Diagnosis 9/22/2017

Pharmacist Objectives. Pulmonary Update. Outline. Technician Objectives. GOLD Guidelines. COPD Diagnosis 9/22/2017 Pharmacist Objectives Pulmonary Update Patty Marshik, PharmD Associate Professor University of New Mexico College of Pharmacy pmarshik@salud.unm.edu Discuss the new Global Initiative for Chronic Obstructive

More information

ANTINEOPLASTIC DRUGS CHAPTER 21. Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component

ANTINEOPLASTIC DRUGS CHAPTER 21. Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component ANTINEOPLASTIC DRUGS CHAPTER 21 Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component Tx of malignancies Antineoplastic drugs: methotrexate

More information

INHALATION TECHNIQUES FOR CHILDREN AND Adolescents Oslo University Hospital, RIKSHOSPITALET

INHALATION TECHNIQUES FOR CHILDREN AND Adolescents Oslo University Hospital, RIKSHOSPITALET INHALATION TECHNIQUES FOR CHILDREN AND Adolescents Oslo University Hospital, RIKSHOSPITALET DIVISION OF PAEDIATRIC AND ADOLESCENT MEDICINE (BARNEKLINIKKEN) VOKSENTOPPEN The information contained in this

More information

II: Moderate Worsening airflow limitations Dyspnea on exertion, cough, and sputum production; patient usually seeks medical

II: Moderate Worsening airflow limitations Dyspnea on exertion, cough, and sputum production; patient usually seeks medical Table 3.1. Classification of COPD Severity Stage Pulmonary Function Test Findings Symptoms I: Mild Mild airflow limitations +/ Chronic cough and sputum production; patient unaware of abnormal FEV 1 80%

More information

Respiratory Care 2. Clinical Skills School of Medicine 2015/16

Respiratory Care 2. Clinical Skills School of Medicine 2015/16 Respiratory Care 2 Clinical Skills School of Medicine 2015/16 Learning Objectives Identify the different types of inhalers and demonstrate the correct inhaler techniques for the different inhalers. Demonstrate

More information

FIGURE 17. USUAL DOSAGES FOR LONG-TERM CONTROL MEDICATIONS*

FIGURE 17. USUAL DOSAGES FOR LONG-TERM CONTROL MEDICATIONS* FIGURE 17. USUAL DOSAGES FOR LONG-TERM CONTROL MEDICATIONS* 0 4 Years Age and Adults Potential Adverse Effects Inhaled Corticosteroids (See Figure 18, Estimated Comparative Daily Dosages for ICSs. ) Oral

More information

Asthma COPD Update 2018

Asthma COPD Update 2018 Asthma COPD Update 2018 Roger Hefflinger, Pharm.D. Clinical Associate Professor ISU COP Clinical Teaching Pharmacist Family Medicine Residency of Idaho In support of improving patient care, Idaho State

More information

COPD Medications Coverage Summary Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes

COPD Medications Coverage Summary Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes COPD Medications Coverage Summary Drug Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes Ventolin MDI + generics Yes Yes Ventolin Diskus NO NO Yukon Pharmacare/Chronic Disease Program

More information

Aerospan (flunisolide)

Aerospan (flunisolide) STRENGTH DOSAGE FORM ROUTE GPID 80mcg/actuation HFA aerosol inhaler w/ Inhaled 35718 8.9 g/canister adapter MANUFACTURER Meda Pharmaceuticals INDICATION Aerospan Inhalation Aerosol is indicated for the

More information

Home Management Plan. Cover Page

Home Management Plan. Cover Page Home Management Plan Cover Page What is Asthma? Asthma is a chronic disease of the lungs caused by swelling and irritation in the lining of airways Tightness of the airway muscles Excess mucus in the airways

More information

reslizumab (Cinqair )

reslizumab (Cinqair ) Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

Asthma Pharmacotherapy 2017: Stepwise Approach to Managing Asthma

Asthma Pharmacotherapy 2017: Stepwise Approach to Managing Asthma Asthma Pharmacotherapy 2017: Stepwise Approach to Managing Asthma Webinar for Michigan Center for Clinical Systems Improvement (Mi-CCSI) Karen Meyerson, MSN, APRN, NP-C, AE-C Director, Commercial Care

More information

Taking Control of Asthma Through Proper Medication Selection and the Use of Asthma Action Plans Julie M. Koehler, Pharm.D., FCCP

Taking Control of Asthma Through Proper Medication Selection and the Use of Asthma Action Plans Julie M. Koehler, Pharm.D., FCCP Taking Control of Asthma Through Proper Medication Selection and the Use of Asthma Action Plans Julie M. Koehler, Pharm.D., FCCP Associate Dean for Clinical Education and External Affiliations & Professor

More information

benralizumab (Fasenra )

benralizumab (Fasenra ) Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

First to Market or 505 (b)2 CMC Considerations IPAC-RS/UF Orlando Inhalation Conference Orlando, Florida

First to Market or 505 (b)2 CMC Considerations IPAC-RS/UF Orlando Inhalation Conference Orlando, Florida First to Market or 505 (b)2 CMC Considerations IPAC-RS/UF Orlando Inhalation Conference Orlando, Florida Prasad Peri, Ph.D., Branch Chief, ONDQA, FDA March 19, 2014 1 Topics for discussion Introduction

More information

PATIENT INFORMATION. ADVAIR DISKUS [AD vair DISK us] (fluticasone propionate and salmeterol inhalation powder) for oral inhalation

PATIENT INFORMATION. ADVAIR DISKUS [AD vair DISK us] (fluticasone propionate and salmeterol inhalation powder) for oral inhalation PATIENT INFORMATION ADVAIR DISKUS [AD vair DISK us] (fluticasone propionate and salmeterol inhalation powder) for oral inhalation What is ADVAIR DISKUS? ADVAIR DISKUS combines the inhaled corticosteroid

More information

STRIVERDI RESPIMAT (olodaterol hcl) aerosol

STRIVERDI RESPIMAT (olodaterol hcl) aerosol STRIVERDI RESPIMAT (olodaterol hcl) aerosol Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy

More information

Up in FLAMES: Stable Chronic Obstructive Pulmonary Disease (COPD) Management. Colleen Sakon, PharmD BCPS September 27, 2018

Up in FLAMES: Stable Chronic Obstructive Pulmonary Disease (COPD) Management. Colleen Sakon, PharmD BCPS September 27, 2018 Up in FLAMES: Stable Chronic Obstructive Pulmonary Disease (COPD) Management Colleen Sakon, PharmD BCPS September 27, 2018 Disclosures I have no actual or potential conflicts of interest 2 Objectives Summarize

More information

NHS Northern, Eastern and Western Devon Clinical Commissioning Group NHS South Devon and Torbay Clinical Commissioning Group

NHS Northern, Eastern and Western Devon Clinical Commissioning Group NHS South Devon and Torbay Clinical Commissioning Group NHS Northern, Eastern and Western Devon Clinical Commissioning Group NHS South Devon and Torbay Clinical Commissioning Group Inhaler technique and respiratory conditions Guidance Sheet 16 When diagnosed

More information

Position within the Organisation

Position within the Organisation ASTHMA TREATMENT GUIDELINES Document Description Document Type Service Application Guidelines All healthcare professionals(hcps) caring for patients with asthma Version 4.0 Ratification date September

More information

Asthma Description. Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways.

Asthma Description. Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways. Asthma Asthma Description Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways. Symptoms of asthma In susceptible individuals, this inflammation causes recurrent

More information

GMMMG COPD Formulary Inhaler Options October 2017

GMMMG COPD Formulary Inhaler Options October 2017 BNF 3.1.1 Adrenocepter agonists (SABA) Salbutamol Salbutamol Terbutaline Brand name Airsalb Ventolin Evohaler Bricanyl Turbohaler Device MDI MDI Dry powder Strengths 100 microgram 100 microgram 500 microgram

More information

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. Uniform Formulary Review Process Under 10 U.S.C. 1074g, as implemented by 32

More information

Asthma Education. The Keys to Asthma Prevention and Control. what to do when one s asthma is flared! Lucile Packard Children s Hospital.

Asthma Education. The Keys to Asthma Prevention and Control. what to do when one s asthma is flared! Lucile Packard Children s Hospital. Asthma Education Lucile Packa r d Children s H o spit al Created by Rachel Lawler RN, MSN, cpnp, AE-C, NPAT Pulmonary Pediatric Nurse Practitioner Lucile Packard Children s Hospital The Keys to Asthma

More information

Inhaler Devices. Ask the patient/carer to demonstrate the technique and correct accordingly at every opportunity.

Inhaler Devices. Ask the patient/carer to demonstrate the technique and correct accordingly at every opportunity. Inhaler Devices The most effective way of taking most asthma medicines is to inhale them so they get straight into the lungs. The best inhaler device is one that the patient can and will use. The correct

More information

Inhaler technique reminder cards

Inhaler technique reminder cards Inhaler technique reminder cards Produced by the Medicines Optimisation Team NHS NEW Devon CCG For further information visit: www.newdevonccg.nhs.uk/information-for-patients/medicines-and-treatments/100073

More information

MANAGEMENT OF ASTHMA SPRING Presented by:

MANAGEMENT OF ASTHMA SPRING Presented by: MEDS@Work MANAGEMENT OF ASTHMA SPRING 2013 Presented by: Lusia Fomuso PharmD candidate 2014 Olivia Sibailly PharmD candidate 2014 Kimberly Biedka PharmD candidate 2014 Dr. Donna Bartlett PharmD CGP RPh

More information

GINA. At-A-Glance Asthma Management Reference. for adults, adolescents and children 6 11 years. Updated 2017

GINA. At-A-Glance Asthma Management Reference. for adults, adolescents and children 6 11 years. Updated 2017 GINA At-A-Glance Asthma Management Reference for adults, adolescents and children 6 11 years Updated 2017 This resource should be used in conjunction with the Global Strategy for Asthma Management and

More information

Provider Respiratory Inservice

Provider Respiratory Inservice Provider Respiratory Inservice 2 Welcome Opening Remarks We will cover: Definition of Asthma & COPD Evidence based guidelines for diagnosis, evaluation, and management of asthma Evidence based guidelines

More information

Inhaled Corticosteroids Drug Class Prior Authorization Protocol

Inhaled Corticosteroids Drug Class Prior Authorization Protocol Inhaled Corticosteroids Drug Class Prior Authorization Protocol Line of Business: Medicaid P&T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed through review

More information

Learning Objectives 4/26/2012. Review normal lung function and COPD pathophysiology Discuss pharmacological management

Learning Objectives 4/26/2012. Review normal lung function and COPD pathophysiology Discuss pharmacological management Marliese Gibson PharmD HospiScript, a Catalyst Rx Company May 16, 2012 Chronic Obstructive Pulmonary Disease Learning Objectives Review normal lung function and COPD pathophysiology Discuss pharmacological

More information